CrushSCI.com
129.3Average days
131Median days
74Fastest days
192Longest days
1372025 publications

Paper Review Records

All Paper Review Records

13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

192 days

From aseptic ideal to microbial community balance: The shift in gut microbiota management models for hematopoietic stem cell transplant patients

Authors
Su Liu; Yong-Wang Feng; Cuihong ZhuShow moreShow less
Affiliations
Department of Blood and Marrow Transplantation, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Tianjin, 300208, China; Microbiology Laboratory, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Tianjin, 300208, China; Department of Infection Prevention and Control, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Tianjin, 300208, ChinaShow moreShow less
Source PDF DOI Publisher page
118 days

Clinical relevance of the newly reclassified HLA-C*04:09L low-expression allele in allogeneic hematopoietic cell transplantation: a case report

Authors
Rodrigo Gil-Manso; Lucía López-Corral; Juan López-Pérez; Daniel Arroyo-Sánchez; Vivian Lizeth Stewart Delcid; Isabel Jiménez Hernaz; Pilar Terradillos Sánchez; Ariadna Vicente Parra; Nuria Calzada Nieto; Jairo Eduardo Niño-Ramírez; Almudena Cabero; Mónica Cabrero; Ana África Martín López; Sara Marcos Asensio; Lourdes Vázquez; Estefanía Pérez López; Fermín Sánchez-Guijo; Francisco Javier Gil-Etayo; Amalia Tejeda VelardeShow moreShow less
Affiliations
Department of Hematology, University Hospital of Salamanca, Salamanca, Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainShow moreShow less
Source PDF DOI Publisher page
114 days

CD43 is a checkpoint against KLRG-1+CD49dhi effector CD8+ T cell formation

Authors
Yukai Tang; Joel S. Freibaum; Gregory S. Cohen; Riley P. Leathem; Scott M. KrummeyShow moreShow less
Affiliations
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USAShow moreShow less
Source PDF DOI Publisher page
140 days

The role of heparanase in organ allograft rejection and the effect of heparanase inhibition on allograft survival

Authors
Adrian Hibberd; David Clark; Paul Trevillian; Raewyn Billings; Christopher Oldmeadow; Rodney Scott; Katherine Baines; Munish Heer; Simon Chiu; John AttiaShow moreShow less
Affiliations
Newcastle Transplant Unit, Division of Surgery, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia; School of Medicine and Population Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW, Australia; Immune Health Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia; Department of Pathology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW, AustraliaShow moreShow less
Source PDF DOI Publisher page
74 days

Donor-specific antibodies in vascularized composite allotransplantation: A multicenter study

Authors
Xavier Charmetant; Gaëlle Wehrlen; Jean Kanitakis; Jean-Paul Duong van Huyen; Philippe Drabent; Lionel Badet; Bernard Devauchelle; Sylvie Testelin; Aram Gazarian; Christophe Gaillard; Claudia Sardu; Dorota Kaminska; Simon Kay; Patrik Lassus; Özlenen Özkan; Bohdan Pomahac; Martin Kauke-Navarro; Simon Talbot; Olivier Thaunat; Valérie Dubois; Emmanuel Morelon; Palmina PetruzzoShow moreShow less
Affiliations
Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France; Claude Bernard University (Lyon 1), Villeurbanne, France; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France; Department of Pathology, Enfants Malades, Necker Hospital, APHP, Paris, France; Department of Urology and Transplant Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France; Department of Maxillofacial Surgery, CHU Amiens, Amiens, France; Department of Upper Limb Orthopaedic Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; Division of Nephrology, Transplantology and Clinical Immunology at 4th Military Clinical Hospital; Department of Non-Procedural Clinical Sciences, Faculty of Medicine, Wrocław University of Science and Technology, Wroclaw, Poland; Department of Plastic and Reconstructive Surgery, Leeds General Infirmary, Leeds, United Kingdom; Department of Plastic and Reconstructive Surgery, Helsinki University Hospital, University of Helsinki, Finland; Department of Plastic and Reconstructive Surgery, Akdeniz University Faculty of Medicine, Antalya, Turkey; Department of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, USA; Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; HLA laboratory, Franch National Blood Service (EFS), Décines, France; Department of Surgical Sciences, University of Cagliari, Cagliari, ItalyShow moreShow less
Source PDF DOI Publisher page
103 days

ABO blood group associations with corneal and organ failure diagnoses on the Ecuadorian transplant waiting list: A 2017–2022 observational cohort study

Authors
Erick Velasteguí-Peñafiel; Felipe Ortiz; María Esther Castillo; Doménica Yepez; Leonardo Callatasig; Carla Vivanco-Arias; Anghely Vinueza-Flores; Andrea Garcia-AnguloShow moreShow less
Affiliations
Laboratorio de Inmunología Experimental y Cáncer (LIEC), Doctoral Program in Biomedical Sciences, Graduate School, Faculty of Medicine, Universidad de Chile, Santiago 8380453, Chile; Instituto Nacional de Donación y Trasplante de Órganos, Tejidos y Células (INDOT), Quito, Ecuador; Universidad de las Americas (UDLA), Quito-Ecuador; Universidad Politécnica Salesiana (UPS), Quito-Ecuador; Universidad Central del Ecuador (UCE), Quito-Ecuador; Centro de Estudios e Investigaciones Estadísticas, Escuela Superior Politécnica del Litoral, 16 (ESPOL), Guayaquil, Ecuador; Facultad de Ciencias Naturales y Matemáticas, Escuela Superior Politécnica del Litoral (ESPOL), Guayaquil, EcuadorShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Transplant Immunology take to review a manuscript?

As of 2026-11-19, CrushSCI has 13 complete review records for Transplant Immunology. The fastest paper went from submission to acceptance in 74 days (Donor-specific antibodies in vascularized composite allotransplantation: A multicenter study, received 2026-06-05, accepted 2026-08-18); the slowest took 192 days. The average is 129.3 days and the median is 131 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.